Search Results - "Dobbelstein, Christiane"

Reduced-intensity, risk factor–stratified immunosuppression for acquired hemophilia A: single-center observational study by Dobbelstein, Christiane, Moschovakis, Georgios Leandros, Tiede, Andreas

“…Immunosuppressive therapy (IST) is administered to patients with acquired hemophilia A (AHA) to eradicate autoantibodies against coagulation factor VIII…”
Get full text

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care—SAKK 33/99 by PASSWEG, Jakob R, GIAGOUNIDIS, Aristoteles A. N, GANSER, Arnold, SIMCOCK, Mathew, AUL, Carlo, DOBBELSTEIN, Christiane, STADLER, Michael, OSSENKOPPELE, Gert, HOFMANN, Wolf-Karsten, SCHILLING, Kristina, TICHELLI, André

“…Immunosuppressive treatment is reported to improve cytopenia in some patients with myelodysplastic syndrome (MDS). Combined antithymocyte globulin (ATG) and…”
Get full text

Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia by Panagiota, Victoria, Dobbelstein, Christiane, Werwitzke, Sonja, Ganser, Arnold, Cooper, Nina, Sachs, Ulrich J, Tiede, Andreas

“…Vaccine-induced thrombotic thrombocytopenia (VITT), or thrombosis with thrombocytopenia syndrome (TTS), is a rare but serious complication of adenovirus-based…”
Get full text

Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study by Tiede, Andreas, Hofbauer, Christoph J., Werwitzke, Sonja, Knöbl, Paul, Gottstein, Saskia, Scharf, Rüdiger E., Heinz, Jürgen, Groß, Jürgen, Holstein, Katharina, Dobbelstein, Christiane, Scheiflinger, Fritz, Koch, Armin, Reipert, Birgit M.

“…Neutralizing autoantibodies against factor VIII (FVIII), also called FVIII inhibitors, are the cause of acquired hemophilia A (AHA). They are quantified in the…”
Get full text

Immunosuppressive therapy for myelodysplastic syndromes by Dobbelstein, Christiane, Ganser, Arnold

“…Myelodysplastic syndromes (MDS) comprise a heterogeneous group of diseases characterized by bone marrow failure, marrow dysplasia, and a tendency to evolve to…”
Get more information

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study by Burgmann, Christian Herbert, Sachs, Ulrich J., Trautmann-Grill, Karolin, Pfrepper, Christian, Knöbl, Paul, Greil, Richard, Oldenburg, Johannes, Miesbach, Wolfgang, Holstein, Katharina, Eichler, Hermann, Möhnle, Patrick, Höpting, Matthias, Dobbelstein, Christiane, Klamroth, Robert, Tiede, Andreas

“…Persons with acquired hemophilia A are often older and suffer from comorbidity or frailty. Little is known about the impact on clinically relevant outcomes of…”
Get full text

Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study by Tiede, Andreas, Hart, Christina, Knöbl, Paul, Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus, Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja, Klamroth, Robert

“…Acquired haemophilia A is caused by neutralising autoantibodies against coagulation factor VIII, leading to severe bleeding. Standard treatment involves…”
Get full text

Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study by Holstein, Katharina, Smith, Andrea, Knöbl, Paul, Dobbelstein, Christiane, Miesbach, Wolfgang A., Spannagl, Michael, Heinz, Jürgen, Scholz, Ute, Eichler, Hermann, Huth-Kühne, Angela, Klamroth, Robert, Koch, Armin, Tiede, Andreas

“…Background: Acquired hemophilia A (AHA) is a serious bleeding disorder characterized by the formation of autoantibodies against coagulation factor VIII…”
Get full text

Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation by Dobbelstein, Christiane E, Dammann, Elke, Weissinger, Eva M, Stadler, Michael, Eder, Matthias, Schlegelberger, Brigitte, Ganser, Arnold, Gohring, Gudrun

“…Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for patients with high-risk acute myeloid leukemia (AML) and myelodysplastic…”
Get full text

Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS by Dobbelstein, Christiane E, Metzger, Jochen, Dammann, Elke, Borchert, Uwe, Buchholz, Stefanie, Stadler, Michael, Eder, Matthias, Krauter, Juergen, Ganser, Arnold, Mischak-Weissinger, Eva

“…Abstract 4128 Allogeneic stem cell transplantation (SCT) is an established treatment for many severe disorders of hematopoiesis. Although SCT has considerable…”
Get full text

Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation by Weissinger, Eva M., Wolff, Daniel, Metzger, Jochen, Dobbelstein, Christiane E, Buchholz, Stefanie, Dammann, Elke, Borchert, Uwe, Krons, Annika, Diedrich, Helmut, Stadler, Michael, Dickinson, Anne M, Holler, Ernst, Greinix, Hildegard T., Krauter, Juergen, Ganser, Arnold

“…Abstract 1970 Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for many hematologic malignancies and non-malignant…”
Get full text

Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter? by Dobbelstein, Christiane, Kamal, Haytham, Dammann, Elke, Mischak-Weissinger, Eva, Stadler, Michael, Krauter, Juergen, Ganser, Arnold, Eder, Matthias

“…Background: There is some evidence that microchimerism plays a role in outcome of HLA-identical stem cell transplantation (SCT). Evaluation of primacy of birth…”
Get full text

Immunosuppressive treatment strategies in low-risk MDS by Ganser, Arnold, Passweg, Jakob, Stadler, Michael, Dobbelstein, Christiane, Weissinger, Eva M

“…Summary Ineffective haematopoiesis with peripheral cytopenias despite normo- or hypercellular bone marrow is the hallmark of the myelodysplastic syndromes…”
Get full text

Immunosuppression for Patients with Low and Intermediate Risk Myelodysplastic Syndrome: A Prospective Randomized Multicenter Trial Comparing Antithymocyte Globulin + Cyclosporine with Best Supportive Care: SAKK 33/99 by Passweg, Jakob R., Giagounidis, Aristoteles, Simcock, Mathew, Aul, Carlo, Dobbelstein, Christiane, Stadler, Michael, Ossenkoppele, Gert, Hofmann, Wolf K., Tichelli, Andre, Ganser, Arnold

“…Immunosuppressive treatment has been reported to improve cytopenia in some patients with myelodysplastic syndrome (MDS). The combined use of anti-thymocyte…”
Get full text

Atypical Presentations of EBV Reactivation and EBV-Associated PTLD Post-HSCT: Implication for Routine EBV Surveillance after Allogeneic HSCT? by Dobbelstein, Christiane E., Kamal, Haytham M., Dammann, Elke, Hertenstein, Bernd, Weissinger, Eva M., Ganser, Arnold

“…Allogeneic hematopoietic stem cell transplantation (HSCT), an effective treatment for leukemia and other disorders, produces profound immune deficiency in the…”
Get full text

Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation by Lehmann, Ulrich, Dobbelstein, Christiane, Fenner, Martin, Römermann, Daniel, Hasemeier, Britta, Metzig, Kathleen, Steinemann, Doris, Büsche, Guntram, Krauter, Jürgen, Ganser, Arnold, Kreipe, Hans

Get full text

Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15 INK⁴b gene methylation and high global DNA methylation by Lehmann, Ulrich, Dobbelstein, Christiane, Fenner, Martin, Römermann, Daniel, Hasemeier, Britta, Metzig, Kathleen, Steinemann, Doris, Büsche, Guntram, Krauter, Jürgen, Ganser, Arnold, Kreipe, Hans

Get full text

Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high gene methylation and high global DNA methylation by Lehmann, Ulrich, Dobbelstein, Christiane, Fenner, Martin, Römermann, Daniel, Hasemeier, Britta, Metzig, Kathleen, Steinemann, Doris, Büsche, Guntram, Krauter, Jürgen, Ganser, Arnold, Kreipe, Hans

Get full text

Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment of Older AML Patients: First Results of a Multicenter Phase II Study by Lübbert, Michael, Rüter, Björn, Schmid, Mathias, Knipp, Sabine, Germing, Ulrich, Dobbelstein, Christiane, Eimermacher, Hartmut, Deschler, Barbara, Claus, Rainer, Schlenk, Richard, Ganser, Arnold, Döhner, Hartmut, Schmoor, Claudia, Henß, Hartmut

“…Background: Few therapeutic options exist for older AML patients (pts) in whom induction chemotherapy is not feasible. Encouraged by the marked activity and…”
Get full text

Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation: An Analysis on Behalf of the Center for International Blood and Marrow Transplantation by Dobbelstein, Christiane, Ahn, Kwang Woo, Haagenson, Michael, Hale, Gregory A, van Rood, Jon J, Miklos, David, Waller, Edmund K, Spellman, Stephen R, Fernandez-Vina, Marcelo, Ganser, Arnold, Aljurf, Mahmoud, Bornhaeuser, Martin, Gupta, Vikas, Marino, Susan R, Pollack, Marilyn S, Reddy, Vijay, Eder, Matthias, Lee, Stephanie J

“…Abstract Allogeneic stem cell transplantation (SCT) is the most effective treatment option for many hematologic malignancies, but graft-versus-host disease…”
Get full text